1. Background
2. Methods
3. Results
| Case Number | Age, mo | Sex | Latency, d | Clinical Findings | Onset of Nail Changes (Month, Year) | Treatment |
|---|---|---|---|---|---|---|
| 1 | 23 | Female | 27 | Onychomadesis | Jan 2019 | Symptomatic |
| 2 | 36 | Male | 30 | Onychomadesis | Jan 2019 | Symptomatic |
| 3 | 28 | Male | 29 | Onychomadesis | Feb 2019 | Symptomatic |
| 4 | 36 | Female | 28 | Onychomadesis | Mar 2019 | Symptomatic |
| 5 | 16 | Male | 33 | Onychomadesis | Apr 2019 | Symptomatic |
| 6 | 20 | Male | 32 | Onychomadesis | May 2019 | Symptomatic |
| 7 | 48 | Male | 29 | Onychomadesis | May 2019 | Symptomatic |
| 8 | 54 | Male | 23 | Onychomadesis | Jun 2019 | Symptomatic |
| 9 | 42 | Female | 40 | Onychomadesis | Jun 2019 | Antibiotics |
| 10 | 36 | Male | 30 | Beau’s lines | Jul 2019 | Symptomatic |
| 11 | 24 | Male | 33 | Onychomadesis | Jul 2019 | Symptomatic |
| 12 | 18 | Female | 36 | Onychomadesis | Jul 2019 | Symptomatic |
| 13 | 84 | Female | 22 | Beau’s lines | Aug 2019 | Symptomatic |
| 14 | 126 | Male | 28 | Beau’s lines | Aug 2019 | Symptomatic |
| 15 | 96 | Male | 33 | Onychomadesis | Sep 2019 | Symptomatic |
| 16 | 90 | Female | 31 | Onychomadesis | Sep 2019 | Symptomatic |
| 17 | 60 | Male | 41 | Onychomadesis | Sep 2019 | Antifungal |
| 18 | 16 | Female | 38 | Beau’s lines | Sep 2019 | Symptomatic |
| 19 | 18 | Male | 35 | Onychomadesis | Sep 2019 | Symptomatic |
| 20 | 72 | Female | 37 | Onychomadesis | Sep 2019 | Symptomatic |
| 21 | 48 | Male | 42 | Onychomadesis | Sep 2019 | Symptomatic |
| 22 | 36 | Male | 35 | Onychomadesis | Oct 2019 | Symptomatic |
| 23 | 24 | Female | 33 | Beau’s lines | Oct 2019 | Symptomatic |
| 24 | 36 | Female | 22 | Onychomadesis | Oct 2019 | Symptomatic |
| 25 | 18 | Male | 35 | Onychomadesis | Oct 2019 | Symptomatic |
| 26 | 30 | Female | 40 | Beau’s lines | Oct 2019 | Symptomatic |
| 27 | 42 | Male | 35 | Beau’s lines | Oct 2019 | Symptomatic |
| 28 | 15 | Female | 28 | Onychomadesis | Oct 2019 | Symptomatic |
| 29 | 32 | Female | 42 | Beau’s lines | Oct 2019 | Antifungal |
| 30 | 48 | Male | 35 | Onychomadesis | Oct 2019 | Symptomatic |
| 31 | 60 | Female | 30 | Onychomadesis | Oct 2019 | Symptomatic |
| 32 | 36 | Male | 35 | Onychomadesis | Nov 2019 | Symptomatic |
| 33 | 30 | Female | 28 | Beau’s lines | Nov 2019 | Symptomatic |
| 34 | 24 | Male | 30 | Onychomadesis | Nov 2019 | Symptomatic |
| 35 | 36 | Male | 42 | Onychomadesis | Sep,2020 | Symptomatic |
| 36 | 18 | Female | 34 | Onychomadesis | Oct 2020 | Symptomatic |
| 37 | 30 | Male | 35 | Beau’s lines | Oct 2020 | Symptomatic |
| 38 | 48 | Female | 30 | Onychomadesis | Oct 2020 | Symptomatic |
| 39 | 60 | Male | 32 | Beau’s lines | Oct 2020 | Symptomatic |
| 40 | 30 | Male | 30 | Onychomadesis | Nov 2020 | Symptomatic |
Nail changes following Hand foot-mouth disease (HFMD). A, A 15-month-old female with right upper limb nails showing onychomadesis and Beau’s lines; B, An 18-month-old male with great toenail with onychomadesis; C, A 54-month-old male with onychomadesis in both upper limb nails; D, A 24- month-old female with nail plate break in upper limb; E, A 60-month-old male with onychomadesis.
